Consolidated Statement of Cash Flows (USD $) In Millions, unless otherwise specified	12 Months Ended
	Dec. 28, 2013	Dec. 29, 2012	Dec. 31, 2011
Operating Activities
Net income	$ 6,787	$ 6,214	$ 6,462
Depreciation and amortization	2,663	2,689	2,737
Stock-based compensation expense	303	278	326
Merger and integration costs	10	16	329
Cash payments for merger and integration costs	(25)	(83)	(377)
Restructuring and impairment charges	163	279	383
Cash payments for restructuring charges	(133)	(343)	(31)
Restructuring and other charges related to the transaction with Tingyi		176
Cash payments for restructuring and other charges related to the transaction with Tingyi	(26)	(109)
Non-cash foreign exchange loss related to Venezuela devaluation	111
Excess tax benefits from share-based payment arrangements	(117)	(124)	(70)
Pension and retiree medical plan contributions	(262)	(1,865)	(349)
Pension and retiree medical plan expenses	663	796	571
Deferred income taxes and other tax charges and credits	(1,058)	321	495
Change in accounts and notes receivable	(88)	(250)	(666)
Change in inventories	4	144	(331)
Change in prepaid expenses and other current assets	(51)	89	(27)
Change in accounts payable and other current liabilities	1,007	548	520
Change in income taxes payable	86	(97)	(340)
Other, net	(349)	(200)	(688)
Net Cash Provided by Operating Activities	9,688	8,479	8,944
Investing Activities
Capital spending	(2,795)	(2,714)	(3,339)
Sales of property, plant and equipment	109	95	84
Acquisition of WBD, net of cash and cash equivalents acquired			(2,428)
Investment in WBD			(164)
Cash payments related to the transaction with Tingyi	(3)	(306)
Other acquisitions and investments in noncontrolled affiliates	(109)	(121)	(601)
Divestitures	133	(32)	780
Short-term investments, by original maturity
More than three months – maturities			21
Three months or less, net	61	61	45
Other investing, net	(21)	12	(16)
Net Cash Used for Investing Activities	(2,625)	(3,005)	(5,618)
Financing Activities
Proceeds from issuances of long-term debt	4,195	5,999	3,000
Payments of long-term debt	(3,894)	(2,449)	(1,596)
Debt repurchase			(771)
Short-term borrowings, by original maturity
More than three months – proceeds	23	549	523
More than three months – payments	(492)	(248)	(559)
Three months or less, net	1,634	(1,762)	339
Cash dividends paid	(3,434)	(3,305)	(3,157)
Share repurchases – common	(3,001)	(3,219)	(2,489)
Share repurchases – preferred	(7)	(7)	(7)
Proceeds from exercises of stock options	1,123	1,122	945
Excess tax benefits from share-based payment arrangements	117	124	70
Acquisition of noncontrolling interests	(20)	(68)	(1,406)
Other financing	(33)	(42)	(27)
Net Cash Used for Financing Activities	(3,789)	(3,306)	(5,135)
Effect of exchange rate changes on cash and cash equivalents	(196)	62	(67)
Net Increase/(Decrease) in Cash and Cash Equivalents	3,078	2,230	(1,876)
Cash and Cash Equivalents, Beginning of Year	6,297	4,067	5,943
Cash and Cash Equivalents, End of Year	$ 9,375	$ 6,297	$ 4,067